Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion type Assertion NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_head.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion description "[Around 20% of breast cancers (BC) show ERBB2 gene amplification and overexpression of the ERBB2 tyrosine kinase receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_provenance.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion evidence source_evidence_literature NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_provenance.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion SIO_000772 20932292 NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_provenance.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion wasDerivedFrom befree-2016 NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_provenance.
- NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_assertion wasGeneratedBy ECO_0000203 NP844539.RAAyAxki2CwGI-JWj2YvM7FL1a3EEvlBrYoN-eK6S8-20130_provenance.